Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,923,822
-$102,585 QoQ
Shares Held
7,575
-8.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#2,389
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesapeake Wealth Management holds $12,931,041 across 7 Drug Manufacturers - General names. JNJ ranks #4 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,031 | $3,635,471 | |
| 2 | ABBV |
AbbVie Inc.
|
14,357 | $3,612,794 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,024 | $1,930,584 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
7,575 | $1,923,822 | |
| 5 | AMGN |
Amgen Inc
|
3,188 | $1,154,437 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,265 | $360,989 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,477 | $312,944 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,923,822 | 7,575 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,026,407 | 8,290 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,671,741 | 8,078 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,428,474 | 7,704 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,166,857 | 7,639 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,295,872 | 7,814 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,155,368 | 7,989 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,371,027 | 8,460 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,223,359 | 8,370 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,326,264 | 8,384 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,353,605 | 8,636 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,378,231 | 8,849 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $1,522,121 | 9,196 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,416,080 | 9,136 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $1,657,329 | 9,382 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $1,561,231 | 9,557 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $1,726,284 | 9,725 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,869,243 | 10,547 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,755,690 | 10,263 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,748,237 | 10,825 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,018,723 | 12,254 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,115,019 | 12,869 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,101,494 | 13,353 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,042,186 | 13,717 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,959,678 | 13,935 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,785,334 | 13,615 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||